Sijing Li
Impact in
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- Ubiquitin and proteasome pathways 3
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Bin Tang (3 shared papers)Lijun Lin (3 shared papers)Kui Wang (2 shared papers)Meixiao Zhan (2 shared papers)Shengtao Yuan (2 shared papers)Li Sun (2 shared papers)Jinyong He (2 shared papers)Hongyang Li (2 shared papers)
In The Last Decade
Sijing Li
50 papers receiving 623 citations
Peers
Comparison fields: 5 of 100
- Neurology 81
- Cancer Research 65
- Critical Care and Intensive Care Medicine 19
- Oncology 109
- Immunology and Allergy 24
Countries citing papers authored by Sijing Li
This map shows the geographic impact of Sijing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijing Li more than expected).
Fields of papers citing papers by Sijing Li
This network shows the impact of papers produced by Sijing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijing Li. The network helps show where Sijing Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Sijing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 94 | |
| 2 | 2019 | 67 | |
| 3 | 2018 | 45 | |
| 4 | 2017 | 44 | |
| 5 | 2003 | 40 | |
| 6 | 2020 | 34 | |
| 7 | 2019 | 25 | |
| 8 | 2021 | 24 | |
| 9 | 2023 | 23 | |
| 10 | 2024 | 20 | |
| 11 | 2018 | 15 | |
| 12 | 2023 | 14 | |
| 13 | 2022 | 11 | |
| 14 | 2020 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2019 | 10 | |
| 17 | 2021 | 10 | |
| 18 | 2021 | 9 | |
| 19 | 2022 | 9 | |
| 20 | 2022 | 8 |
About Sijing Li
Sijing Li is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Epidemiology and Neurology, having authored 57 papers that have together received 632 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Ubiquitin and proteasome pathways (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Acupuncture Treatment Research Studies (2 papers), Cervical Cancer and HPV Research (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Neurology (81 citations), Cancer Research (65 citations), Critical Care and Intensive Care Medicine (19 citations), Oncology (109 citations) and Immunology and Allergy (24 citations). Sijing Li has collaborated with scholars based in China, France and Italy. Frequent co-authors include Bin Tang, Lijun Lin, Kui Wang, Meixiao Zhan, Shengtao Yuan, Li Sun, Jinyong He, Hongyang Li, Fenbo Ma and Mei Tian. Their work appears in journals such as BMJ Open, Brain and Behavior, Reproductive BioMedicine Online, Phytomedicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.